JP2005510485A5 - - Google Patents

Download PDF

Info

Publication number
JP2005510485A5
JP2005510485A5 JP2003535833A JP2003535833A JP2005510485A5 JP 2005510485 A5 JP2005510485 A5 JP 2005510485A5 JP 2003535833 A JP2003535833 A JP 2003535833A JP 2003535833 A JP2003535833 A JP 2003535833A JP 2005510485 A5 JP2005510485 A5 JP 2005510485A5
Authority
JP
Japan
Prior art keywords
release
formulation
controlled
rumen
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003535833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005510485A (ja
Filing date
Publication date
Priority claimed from AUPR8390A external-priority patent/AUPR839001A0/en
Application filed filed Critical
Publication of JP2005510485A publication Critical patent/JP2005510485A/ja
Publication of JP2005510485A5 publication Critical patent/JP2005510485A5/ja
Pending legal-status Critical Current

Links

JP2003535833A 2001-10-19 2002-10-18 処置の投薬形態、デバイスおよび方法 Pending JP2005510485A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR8390A AUPR839001A0 (en) 2001-10-19 2001-10-19 Dosage form, device and methods of treatment
PCT/AU2002/001426 WO2003033031A1 (en) 2001-10-19 2002-10-18 Dosage form, device and methods of treatment

Publications (2)

Publication Number Publication Date
JP2005510485A JP2005510485A (ja) 2005-04-21
JP2005510485A5 true JP2005510485A5 (enExample) 2006-01-05

Family

ID=3832213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003535833A Pending JP2005510485A (ja) 2001-10-19 2002-10-18 処置の投薬形態、デバイスおよび方法

Country Status (22)

Country Link
US (1) US20050064032A1 (enExample)
EP (1) EP1448151A4 (enExample)
JP (1) JP2005510485A (enExample)
KR (1) KR20050037410A (enExample)
CN (1) CN1571663A (enExample)
AR (1) AR037116A1 (enExample)
AU (5) AUPR839001A0 (enExample)
BR (1) BR0212975A (enExample)
CA (1) CA2463674A1 (enExample)
CR (1) CR7312A (enExample)
EA (1) EA005778B1 (enExample)
EC (1) ECSP045063A (enExample)
HR (1) HRP20040231A2 (enExample)
HU (1) HUP0401808A3 (enExample)
IL (1) IL160754A0 (enExample)
MX (1) MXPA04003679A (enExample)
NO (1) NO20041941L (enExample)
NZ (1) NZ531672A (enExample)
PE (1) PE20030519A1 (enExample)
PL (1) PL368387A1 (enExample)
WO (1) WO2003033031A1 (enExample)
ZA (1) ZA200403743B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRN20030021A1 (it) * 2003-07-21 2005-01-22 Ascor Chimici Srl Composizione di materia comprendente particelle contenenti cloruro di colina da somministrare in forma ruminalmente protetta e post-ruminalmente efficace.
ITMI20041820A1 (it) * 2004-09-24 2004-12-24 Ascor Chimici Srl Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico.
KR100866720B1 (ko) * 2004-12-27 2008-11-05 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매 약물의 안정화 방법
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
NZ554260A (en) * 2007-09-30 2010-05-28 Agres Ltd Selenomethionine andor selenocysteine administration to non-human animals to increase selenium content in protein sources
WO2010126857A1 (en) * 2009-04-28 2010-11-04 Wyeth Llc Parasiticidal combinations of macrocyclic lactones and polyether antibiotics
US8734430B2 (en) 2009-07-31 2014-05-27 Merial Limited Sustained release capsules
AU2014203209B2 (en) * 2009-07-31 2015-11-26 Boehringer Ingelheim Animal Health USA Inc. Sustained release capsules
WO2011075592A1 (en) * 2009-12-17 2011-06-23 Merial Limited Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
FR2992219B1 (fr) * 2012-06-22 2014-07-11 Aditec Lab Composition pour le traitement de l'hypocalcemie chez les ruminants
DK3164117T3 (da) 2014-07-03 2023-12-04 SpecGx LLC Misbrugssikre formuleringer med øjeblikkelig frigivelse omfattende ikke-cellulose-polysaccharider
AU2017216904B2 (en) 2016-02-08 2021-11-18 SpecGx LLC Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties
IL266377B2 (en) * 2016-12-02 2023-10-01 Clexio Biosciences Ltd Gastric residence system
NZ760663A (en) * 2017-06-26 2025-11-28 Boehringer Ingelheim Animal Health Usa Inc Dual active parasiticidal granule compositions, methods and uses thereof
USD909604S1 (en) 2017-08-25 2021-02-02 Argenta Manufacturing Limited Barrel of an intraruminal device
AU2019338076B2 (en) * 2018-09-10 2025-07-31 Argenta Innovation Limited Controlled release formulations in delivery devices
BR112021004523A2 (pt) * 2018-09-10 2021-06-08 Argenta Innovation Limited formulações para liberação sustentada em dispositivos de administração
CA3112030A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
PL4013348T3 (pl) * 2019-08-14 2024-07-08 Elanco Tiergesundheit Ag Nowy ochraniacz skrzydełek do oskrzydlonej kapsułki i sposób jego stosowania
BR112022014865A2 (pt) * 2020-02-07 2022-09-20 Elanco Animal Health Incorporated Cápsula alada
WO2021242481A1 (en) * 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
CA3201057A1 (en) 2020-12-08 2022-06-16 Mark Christopher LAY Improvements to devices and methods for delivery of substances to animals
CN113398337A (zh) * 2021-06-23 2021-09-17 上海市肺科医院 包含抗结核药物缓释植入人工骨载体的脊柱内固定装置
CN118743817B (zh) * 2024-09-04 2025-01-21 中国农业大学 一种瘤胃持续给药系统
CN119454625A (zh) * 2024-10-29 2025-02-18 山东鲁西兽药股份有限公司 一种反刍动物用驱虫中药提取物微量元素维生素缓释丸

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU520409B2 (en) * 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
GB2077586A (en) * 1980-06-12 1981-12-23 Standard Telephones Cables Ltd Sustained-release device
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
US4416659A (en) * 1981-11-09 1983-11-22 Eli Lilly And Company Sustained release capsule for ruminants
NZ203203A (en) * 1982-02-16 1985-09-13 Commw Scient Ind Res Org Controlled release device:gas diffusion limited
IE54171B1 (en) * 1982-06-22 1989-07-05 Univ Glasgow Device for introducing nutrients and/or therapeutic materials into ruminant animals
GB8328916D0 (en) * 1983-10-28 1983-11-30 Castex Prod Pharmaceutical pellet
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
NZ212100A (en) * 1984-06-02 1988-07-28 Castex Prod Rumen bolus; outer casing sheds in segments
US4723958A (en) * 1986-05-23 1988-02-09 Merck & Co., Inc. Pulsatile drug delivery system
US4867980A (en) * 1986-10-10 1989-09-19 Coopers Animal Health Australia Limited Heavy density depot
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4957494A (en) * 1987-06-25 1990-09-18 Alza Corporation Multi-layer delivery system
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US4915949A (en) * 1987-07-13 1990-04-10 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
GB8829089D0 (en) * 1988-12-13 1989-01-25 Coopers Animal Health Intra ruminal device
EP0386440B1 (de) * 1989-02-11 1992-08-05 Bayer Ag Arzneimittel mit kontrollierter Wirkstoffabgabe
US5110598A (en) * 1989-06-30 1992-05-05 Smithkline Beecham Corp. Intermittent release dosage form
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
MX9200339A (es) * 1991-01-28 1992-08-01 Hoechst Ag Preparado para la liberacion controlada de sustancias activas, que son apropiadas como terapeuticos o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes
US5417682A (en) * 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
AU650113B2 (en) * 1991-04-05 1994-06-09 Eli Lilly And Company Sustained release capsule and formulations
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5221278A (en) * 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
DE69531773T2 (de) * 1994-01-20 2004-07-15 Agresearch Ltd. Vorrichtung zur verabreichung von nützlichen stoffen an wiederkäuer
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
HU230454B1 (hu) * 1998-11-02 2016-07-28 Alkermes Pharma Ireland Limited Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
DE19956486A1 (de) * 1999-11-24 2001-06-21 Lohmann Therapie Syst Lts Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen
CA2395892C (en) * 1999-12-31 2014-06-03 Rutgers, The State University Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
AU2001237424A1 (en) * 2000-02-28 2001-09-12 Akzo Nobel N.V. Bodies for the controlled release of active substances

Similar Documents

Publication Publication Date Title
JP2005510485A5 (enExample)
US12324856B2 (en) Oral drug dosage form comprising drug in the form of nanoparticles
RU2340358C2 (ru) Композиция, ингибирующая секрецию кислоты в желудке
ES2330415T3 (es) Sistema para suministro osmotico de agentes activos farmaceuticos.
JP2020506918A (ja) 特定の胃腸部位での制御放出の剤形
EA005778B1 (ru) Дозированная форма, устройство и способы лечения
ES2199982T3 (es) Tableta recubierta de paracetamol y domperidona.
JP2006505566A5 (enExample)
AU2002332975A1 (en) Dosage form, device and methods of treatment
WO2018236678A1 (en) Orally dissolving melatonin formulation with acidifying agent that renders melatonin soluble in saliva
US20120014912A1 (en) Palatable pharmaceutical composition
ES2671926T3 (es) Comprimido recubierto en seco que contiene tegafur, gimeracilo y oteracilo potásico
US20230149296A1 (en) Drug delivery system for the delivery of antiviral agents and contraceptives
CN107582536B (zh) 一种枸橼酸铋钾口腔粘贴片及其制备方法
KR20160076928A (ko) 푸마르산 에스테르를 함유하는 미니-정제 형태의 약제학적 제제
EP3638213A1 (en) Modified-release tiopronin compositions, kits and methods for treating cystinuria and related disorders
US9579330B2 (en) Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
KR20170086053A (ko) 디메틸 푸마르산염을 포함하는 제약학적 매트릭스 제제
US20180318228A1 (en) Method for a slow release of drugs from orally dissolving capsules
US20060193908A1 (en) Extended release formulations of poorly soluble antibiotics
WO2006117803A2 (en) Transmucosal drug delivery systems
CA2612179A1 (en) A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
TR201710637T1 (tr) Ibuprofen, psödoefedri̇n ve vi̇tami̇n c i̇çeren bi̇r farmasöti̇k kompozi̇syon
Nagpal et al. Patent innovations in fast dissolving/disintegrating dosage forms
EP1401403A2 (en) Medicinal compositions comprising a melting core encapsulated in a hydroxypropylmethylcellulose film